Scientific Officer 2: Development of Novel Biomarker Assays

All UK vacanciesAcademic or ResearchScientific Officer 2: Development of Novel Biomarker Assays

Health and Medical,Medicine and Dentistry,Biological Sciences,Biology,Biochemistry

Short info about job

Company: The University of Manchester

Department: Clinical and Experimental Pharmacology Group

Salary: £19,600 + per annum dependent upon experience

Hours: Full Time

Contract type: Fixed-Term/Contract

Type / Role: Academic or Research

Phone: +44-1290 2709747

Fax: +44-29 6913940

E-mail: N\A


Detail information about job Scientific Officer 2: Development of Novel Biomarker Assays. Terms and conditions vacancy

The Clinical and Experimental Pharmacology Group (CEP) aim to enhance clinical trials of new anticancer drugs through biomarker research. A position is available for an experienced Scientific Officer to join the Group, and oversee our effort on the development of novel biomarker assays, complementing in-house technology for ‘rare cell’ enrichment from cancer clinical trial samples. All the required training and supervision will be provided.

The successful candidate will possess a bachelor’s degree in an appropriate scientific discipline e.g. biology, biochemistry, or medical sciences, or have equivalent relevant experience. Also required is first-hand experience of a range of immune assays in the laboratory, including immunocytochemical and immunofluorescent, along with a track record of success in the implementation and utilisation of such assays, e.g. in a clinical setting or for research publications. Highly desirable is a keen interest in cancer biology and previous experience of working in a cancer research setting, plus experience of working to Good Clinical Practice (GCP) standards.

Informal enquiries should be directed to Dr Jonathan Tugwood, email: [email protected]

The Cancer Research UK Manchester Institute (, an Institute of The University of Manchester (, is a world-leading centre for excellence in cancer research.  The Institute is core funded by Cancer Research UK (, the largest independent cancer research organisation in the world. We are currently situated at the internationally-renowned life sciences campus at Alderley Park in Cheshire England, 15 miles from Manchester, a vibrant and dynamic city surrounded by beautiful countryside.

We are partnered with The Christie NHS Foundation Trust (adjacent to the CRUK MI Paterson Building) in South Manchester (, one of the largest cancer treatment centres in Europe.  These factors combine to provide an exceptional environment in which to pursue basic, translational and clinical research programmes.

Our aim is to understand the fundamental basis of cancer and apply that knowledge to developing new treatment strategies for cancer patients.  Our advanced research programmes span a spectrum of cancer research, from the molecular and cellular basis of cancer through to drug discovery, translational research and clinical trials.

The Institute has outstanding laboratory facilities and exceptional core services, including next generation sequencing, microarrays, confocal microscopy, bioinformatics, histology and mass-spectrometry. 

To apply for this position please visit our website:


Closing date: 20 September 2017.


Responds for Scientific Officer 2: Development of Novel Biomarker Assays on FaceBook

Read all comments for Scientific Officer 2: Development of Novel Biomarker Assays. Leave a respond Scientific Officer 2: Development of Novel Biomarker Assays in social networks. Scientific Officer 2: Development of Novel Biomarker Assays on Facebook and Google+